170 related articles for article (PubMed ID: 15580610)
1. Methadone for refractory restless legs syndrome.
Ondo WG
Mov Disord; 2005 Mar; 20(3):345-8. PubMed ID: 15580610
[TBL] [Abstract][Full Text] [Related]
2. A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.
Silver N; Allen RP; Senerth J; Earley CJ
Sleep Med; 2011 May; 12(5):440-4. PubMed ID: 21239226
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of restless legs syndrome with dopamine agonists.
Ondo W; Romanyshyn J; Vuong KD; Lai D
Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
5. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
[TBL] [Abstract][Full Text] [Related]
7. Restless legs syndrome (RLS) with expansion of symptoms to the face.
Buchfuhrer MJ
Sleep Med; 2008 Jan; 9(2):188-90. PubMed ID: 17638589
[TBL] [Abstract][Full Text] [Related]
8. Current guidelines and standards of practice for restless legs syndrome.
Hening WA
Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
[TBL] [Abstract][Full Text] [Related]
9. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of restless legs syndrome with long-term tramadol treatment.
Vetrugno R; La Morgia C; D'Angelo R; Loi D; Provini F; Plazzi G; Montagna P
Mov Disord; 2007 Feb; 22(3):424-7. PubMed ID: 17230457
[TBL] [Abstract][Full Text] [Related]
11. Empirical evaluation of the accuracy of diagnostic criteria for Restless Legs Syndrome.
Benes H; von Eye A; Kohnen R
Sleep Med; 2009 May; 10(5):524-30. PubMed ID: 18996741
[TBL] [Abstract][Full Text] [Related]
12. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.
Trenkwalder C; Stiasny-Kolster K; Kupsch A; Oertel WH; Koester J; Reess J
Mov Disord; 2006 Sep; 21(9):1404-10. PubMed ID: 16755554
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
[TBL] [Abstract][Full Text] [Related]
14. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
15. When restless legs syndrome turns malignant.
Schulte EC; Gross N; Slawik H; Winkelmann J
Sleep Med; 2013 Jun; 14(6):575-7. PubMed ID: 23643657
[TBL] [Abstract][Full Text] [Related]
16. Control of medically refractory restless legs syndrome with intrathecal morphine: case report.
Ross DA; Narus MS; Nutt JG
Neurosurgery; 2008 Jan; 62(1):E263; discussion E263. PubMed ID: 18300885
[TBL] [Abstract][Full Text] [Related]
17. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
19. Intermittent subcutaneous methadone administration in the management of cancer pain.
Centeno C; Vara F
J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
[TBL] [Abstract][Full Text] [Related]
20. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
